Tag: Intranasal Vaccine

Nasal Vaccine
Bharat Biotech Gets Nod For COVID-19 Intra-Nasal Vaccine Phase-3 Trials

Bharat Biotech has received approval from the Drug Controller General of India to conduct phase-3 trials for its COVID-19 intra-nasal vaccine (BBV154), sources in the company said on Friday.

  • Friday, 28 January 2022
Bharat Biotech Gets Nod For Phase 2/3 Trials Of Intranasal Vaccine
Bharat Biotech Gets Nod For Phase 2/3 Trials Of Intranasal Vaccine

The regulatory approval has been received for conducting "Phase 2 randomised, multi-centric, clinical trial of heterologous prime-boost combination of SARS-CoV-2 vaccines to evaluate the immunogenicity and safety of BBV152 (Covaxin) with BBV154 (Adenoviral Intranasal Covid-19 vaccine) in healthy volunteers.

  • Friday, 13 August 2021
scrollToTop